Cargando...
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
BACKGROUND: Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negati...
Gardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4226953/ https://ncbi.nlm.nih.gov/pubmed/25011475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-498 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|